Highly Immunogenic Ebola Antigens

Creative Diagnostics Ebola Antigen Products provide a reliable and high-performance solution for the detection and study of Ebola virus.The antigens are produced through advanced expression and purification methods with optimized quality control systems to achieve high sensitivity and specificity and reproducibility. The validation process for each antigen ensures reliable performance and stable operation and precise viral detection. The Ebola Antigen Products serve multiple purposes in virology research and vaccine development and antiviral drug discovery and diagnostic assay establishment for infectious disease research and immune response analysis and therapeutic innovation.

Talk to our experts Available Products

Why Choose Creative Diagnostics' Ebola Antigens?

Creative Diagnostics offers Ebola Antigen Products for highly sensitive and specific detection of Ebola virus in biological samples. The antigens undergo advanced expression and purification methods followed by quality control validation to achieve high accuracy and stability and reproducibility. These methods are used for viral detection and Ebola pathogenesis studies and immune response analysis and vaccine development and antiviral research. Our product advantages:

• High Sensitivity: Effectively detects low levels of Ebola virus-related antibodies or antigens.
• High Specificity:High affinity with the Ebola virus, preventing cross-reactivity and ensuring accurate test results.
• Reliable Immunogenicity:Suitable as a core material for vaccine development and immunology research.
• Batch-to-Batch Consistency:Strict quality control ensures reproducible research and test results.
• Structural Stability:Maintains protein conformation, suitable for long-term storage and use.
• Broad Application Range:Widely used in diagnostic testing, vaccine development, drug screening, immunology research, and more.
• Customizability:Available in various formats (such as recombinant protein, purified protein, and peptide fragments) to meet diverse research and industry needs.

Get a Quote

Case Study

Application of Ebola Antigen Products in Vaccine Development

Background:

The Ebola virus continues to pose a significant threat because it causes recurring outbreaks in various regions of Africa. Rapid development of effective vaccines is critical to control the disease.Scientists required dependable Ebola antigens for conducting immune response tests and developing sophisticated vaccine formulations.

Objective:

The evaluation of candidate Ebola vaccines depends on in vitro and in vivo tests which use high-quality Ebola antigen products as reference materials to measure immune response.

Method:

• The recombinant Ebola glycoprotein (GP) and nucleoprotein (NP) antigens were purchased from Creative Diagnostics.
• The ELISA plates received antigen coatings for detecting antibodies from immunized mice.
• The researchers conducted flow cytometry and neutralization assays to measure T-cell and B-cell responses at the specific level.
• The verification process for antigen stability and batch-to-batch consistency guaranteed that the results would be consistent.

Results:

• The vaccinated mice developed robust antibody responses which could be detected through Ebola antigen tests.
• The GP-coated assays confirmed T-cell activation.
• The results showed consistent results between different antigen batches which proved the high reproducibility and reliability of the test.
• The antigens allowed researchers to make exact comparisons between various vaccine candidates which sped up the process of identifying the most effective formulation.

Conclusion:

The high-quality Ebola Antigen Products enabled precise immune system tracking which accelerated the development of Ebola vaccines through safer and more efficient processes.